Local gastric and serum amoxicillin concentrations after different oral application forms.
about
Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pyloriEfficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO₂.Formulation, characterization and physicochemical evaluation of amoxicillin effervescent tablets.Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases.Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.Diagnostic methods for Helicobacter pylori detection and eradicationEfficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy.Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Applications of poly(ethylene oxide) in controlled release tablet systems: a review.Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. PyloriModification of drug delivery to improve antibiotic targeting to the stomach.Use of cryomicrotomy to study gastric diffusion of amoxicillin in guinea pigs.Reduced amoxicillin uptake into human gastric mucosa when gastric juice pH is high.The synthetic antimicrobial peptide pexiganan and its nanoparticles (PNPs) exhibit the anti-helicobacter pylori activity in vitro and in vivo.Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.Wax-incorporated emulsion gel beads of calcium pectinate for intragastric floating drug delivery.Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation.Morphology and buoyancy of oil-entrapped calcium pectinate gel beads.Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin.Optimization and characterization of gastroretentive floating drug delivery system using Box-Behnken design.Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.Factors affecting solubility and penetration of clarithromycin through gastric mucus.Determination of metronidazole in a rat stomach by HPLC for obtaining basic data of the eradication therapy of Helicobacter pylori.Gastrointestinal transit of amoxicillin modified-release tablets and a placebo tablet including pharmacokinetic assessments of amoxicillin.
P2860
Q30847388-C704F9FA-CDDD-47C9-B1C0-E08F2CADA74AQ33697989-A2C65205-A130-4E4D-983C-D0E8ED4B8520Q33797992-474C7052-3663-4CC6-84DC-F9B3F59FC241Q34146947-8541546D-2FA7-424B-A95A-48D48FD60355Q34447742-0EBA5312-030D-42BD-91F3-5983CF086F37Q35110775-2435D4E5-D96C-4923-866C-D5A46BCF6465Q35120681-F2636215-A9E9-46F8-9C87-1D84D02D4ED6Q35200053-C65473FE-345C-4AB1-9F77-739B220B5752Q36549258-91F4AEE3-20B3-4C5F-AC3F-8B358411F1A1Q36723844-D4F99FF1-4DC8-4595-9EA6-29462E9B2545Q38133846-B433DA5A-6E3B-4FAC-82DD-610617F8D628Q38268630-A7AC1823-C128-4824-AAD6-FACF9368BD14Q38543395-DAA4E9D7-B0C5-4CC8-9BF2-5872000BFDD9Q39779423-BA480E1E-1060-4E09-80D1-C2361FDCE823Q39780444-86B6862C-3146-4521-A3DA-5459D485213EQ41451193-D436FA1B-EE51-4250-B306-D509E156DDC6Q41989264-624D2852-4EED-4E1D-ABC6-7257A983C656Q41989586-C4557D3E-D220-49B5-89B9-77A0CDFDED7BQ41989589-D00022C9-2B85-43F4-83D6-D89770EBA8EAQ42115752-02903874-AA17-4428-B3EB-168583DC97A2Q42979956-E289E447-C83A-4B5D-950C-489464A724C5Q44456614-31737A9E-203D-4610-B5CE-B42D323A414BQ45934066-966C2909-C259-4A6C-B825-6D88313A8C25Q46110162-E3FFB9EB-B33D-4C78-8A2D-8C7DDC621BB7Q47330304-A0A88B9F-BA99-4608-BCE1-24DC6AC99F9CQ49425208-32444478-207C-44F7-96DF-E3E7C63537BBQ51583340-4E4E4258-8230-4A1F-8871-383F5C65E931
P2860
Local gastric and serum amoxicillin concentrations after different oral application forms.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Local gastric and serum amoxic ...... ferent oral application forms.
@ast
Local gastric and serum amoxic ...... ferent oral application forms.
@en
type
label
Local gastric and serum amoxic ...... ferent oral application forms.
@ast
Local gastric and serum amoxic ...... ferent oral application forms.
@en
prefLabel
Local gastric and serum amoxic ...... ferent oral application forms.
@ast
Local gastric and serum amoxic ...... ferent oral application forms.
@en
P2093
P2860
P356
P1476
Local gastric and serum amoxic ...... ferent oral application forms.
@en
P2093
Cooreman MP
Hengels KJ
Krausgrill P
P2860
P304
P356
10.1128/AAC.37.7.1506
P407
P577
1993-07-01T00:00:00Z